Agency Forms Undergoing Paperwork Reduction Act Review, 70517-70518 [E6-20539]
Download as PDF
<![CDATA[
70517
Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices
0600)—Extension—National Center for
Health Marketing (NCHM), Coordinating
Center for Health Information and
Service (COCHIS), Centers for Disease
Control and Prevention.
Background and Brief Description
While the overall number of cases of
TB in the U.S. has decreased, rates still
remain high among foreign-born
persons, prisoners, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
The rate of TB cases detected in foreignborn persons has been reported to be
almost nine times higher than the rate
among the U.S. born population. CDC’s
goal to eliminate TB will be virtually
impossible without considerable effort
in assisting heavy disease burden
countries in the reduction of
tuberculosis. As part of the continuing
effort to support both domestic and
global public health objectives for
treatment of tuberculosis (TB),
prevention of multi-drug resistance and
surveillance programs, the National
Center for Health Marketing, Division of
Laboratory Systems (DLS) seeks to
continue to collect information from
domestic private clinical and public
health laboratories twice per year.
Participation and information
collections from international
laboratories are limited to those which
have public health responsibilities for
tuberculosis drug susceptibility testing
and approval by their national
tuberculosis program. The M.
tuberculosis/NTM program supports
this role by monitoring the level of
performance and practices among
laboratories performing M. tuberculosis
susceptibility within the U.S. as well as
internationally to promote high-quality
laboratory testing, resulting in accurate
and reliable results.
Information collected in this program
includes the susceptibility test results of
Number of
respondents
Type of respondents
Form name
Laboratories U.S. and foreign .............................................
Enrollment ............................
Information change ..............
Results Form ........................
Dated: November 29, 2006.
Deborah Holtzman,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. E6–20535 Filed 12–4–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[30Day–07–0670]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
VerDate Aug<31>2005
15:14 Dec 04, 2006
Jkt 211001
Proposed Project
Evaluation of Efficacy of Household
Water Filtration/Treatment Devices in
Households with Private Wells—
Revision (OMB No. 0920–0670)—
National Center for Environmental
Health (NCEH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Centers for Disease Control and
Prevention
ycherry on PROD1PC64 with NOTICES
primary and secondary drugs,
concentrations, and test methods
performed by laboratories on a set of
challenge isolates sent twice yearly. A
portion of the response instrument
collects demographic data such as
laboratory type and the number of tests
performed annually. By providing an
evaluation program to assess the ability
of the laboratories to test for drug
resistant M. tuberculosis and selected
strains of NTM, laboratories have a selfassessment tool to aid in maximizing
their skills in susceptibility testing.
Information obtained from laboratories
on susceptibility testing practices and
procedures assists with determining
variables related to good performance,
with assessing areas for training and
with developing practice standards.
There are no costs to respondents
other than their time. The estimated
annualized burden hours are 165.332.
Estimate of Annualized Burden Hours
Approximately 42.4 million people in
the United States are served by private
wells. Unlike community water systems,
private wells are not regulated by the
U.S. Environmental Protection Agency’s
(EPA) Safe Drinking Water Act (SDWA).
Under the SDWA, EPA sets maximum
contaminant levels (MCLs) for
contaminants in drinking water. A 1997
U.S. General Accounting Office (GAO)
report on drinking water concluded that
users of private wells may face higher
exposure levels to groundwater
contaminants than users of community
water systems. Increasingly, the public
is concerned about drinking water
quality, and the public’s use of water
treatment devices rose from 27% in
1995 to 41% in 2001 (Water Quality
Association, 2001 National Consumer
Water Quality Survey). Studies
evaluating the efficacy of water
treatment devices on removal of
pathogens and other contaminants have
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
2
2
165
1
1
2
Average burden
per response
(in hours)
(5/60) 0.0833
(5/60) 0.0833
(30/60) 0.5
assessed the efficacy of different
treatment technologies.
The purpose of the proposed study is
to evaluate how water treatment device
efficacy is affected by user behaviors
such as maintenance and selection of
appropriate technologies. Working with
public health authorities in Colorado,
Maine, Missouri, Nebraska, North
Carolina, and Wisconsin, NCEH will
recruit 600 households to participate in
a study to determine whether people
using water treatment devices are
protected from exposure to
contaminants found in their well water.
We plan to recruit households on
private well water that use water
filtration/treatment devices to treat tap
water for drinking and cooking. Study
participants will be selected from
geographical areas of each state where
groundwater is known or suspected to
contain contaminants of public health
concern. We will administer a
questionnaire at each household to
obtain information on selection of water
treatment type, adherence to suggested
maintenance, and reasons for use of
treatment device. We will also obtain
samples of treated water and untreated
well water at each household to analyze
for contaminants of public health
concern. There is no cost to respondents
E:\FR\FM\05DEN1.SGM
05DEN1
70518
Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices
other than their time. The total
estimated annual burden hours are 300.
Estimated Annualized Burden Hours
Number of
respondents
Respondents
Participant Solicitation Telephone Screening Questionnaire ......................................................
Household Survey Questionnaire ................................................................................................
Dated: November 28, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–20539 Filed 12–4–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Joint Meeting of the Anti-Infective
Drugs Advisory Committee and the
Drug Safety and Risk Management
Advisory Committee; Amendment of
Notice
AGENCY:
Food and Drug Administration,
HHS.
ycherry on PROD1PC64 with NOTICES
ACTION:
Notice.
The Food and Drug Administration
(FDA) is announcing an amendment to
the notice of joint meeting of the AntiInfective Drugs Advisory Committee
and the Drug Safety and Risk
Management Advisory Committee. This
meeting was announced in the Federal
Register of November 15, 2006 (71 FR
66545). The amendment is being made
to reflect a change in the Location
portion of the document. There are no
other changes.
FOR FURTHER INFORMATION CONTACT:
Sohail Mosaddegh, Center for Drug
Evaluation and Research (HFD–21),
Food and Drug Administration, 5600
Fishers Lane (for express delivery, 5630
Fishers Lane, rm. 1093) Rockville, MD
20857, 301–827–7001, fax: 301–827–
6776, e-mail:
sohail.mosaddegh@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington DC area), codes 301–451–
2530 or 301–451–2535. Please call the
Information Line for up-to-date
information on this meeting.
SUPPLEMENTARY INFORMATION: In the
Federal Register of November 15, 2006,
FDA announced that a joint meeting of
Anti-Infective Drugs Advisory
Committee and the Drug Safety and Risk
Management Advisory Committee
would be held on December 14 and 15,
2006. On page 66545, in the first
column, the Location portion of
document is amended to read as
follows:
Location: Hilton, Maryland
Ballrooms, 8727 Colesville Road, Silver
Spring, MD. The hotel phone number is
301–589–5200.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
Dated: November 29, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. E6–20538 Filed 12–5–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, call the HRSA Reports
Clearance Office on (301) 443–1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Number of
respondents
Form
AENT ....................................................................................
VerDate Aug<31>2005
15:14 Dec 04, 2006
Jkt 211001
PO 00000
Frm 00018
Responses
per
respondent
500
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1200
600
1
1
Average
burden per
response
(in hours)
5/60
20/60
Proposed Project: Advanced Education
Nursing Traineeship (AENT) and Nurse
Anesthetist Traineeship (NAT): In Use
Without Approval
The Health Resources and Services
and Administration (HRSA) provides
training grants to educational
institutions to increase the numbers of
advanced education nurses through the
Advanced Education Nursing
Traineeship (AENT) program and the
Nurse Anesthetist Traineeship (NAT)
program.
HRSA developed the AENT and NAT
tables for the guidance applications for
the two nursing traineeship programs.
The AENT and NAT tables are used
annually by grant applicants that are
applying for AENT and NAT funding.
The funds appropriated for the AENT
and NAT programs are distributed
among eligible institutions based on a
formula. Award amounts are based on
enrollment and graduate data reported
on the tables and two funding factors
(Statutory Funding Preference and
Statutory Special Consideration) to
those institutions which the criteria for
one or both of the funding factors.
The AENT/NAT tables include
information on program participants
such as the number of enrollees, number
of graduates and the types of programs
they are enrolling into and/or from
which they are graduating. These tables
will be available electronically through
Grants.gov. AENT and NAT applicants
will have a single access point to submit
their grant applications and AENT/NAT
Traineeship tables.
Data from the tables will be used in
the award determination and validation
process. Additionally, the data will be
used to ensure programmatic
compliance, report to Congress and
policymakers on the program
accomplishments, and formulate and
justify future budgets for these activities
submitted to OMB and Congress.
The burden estimate for this project is
as follows:
Total
responses
1
E:\FR\FM\05DEN1.SGM
500
05DEN1
Hours per
response
Total burden
hours
1
500
]]>Agencies
[Federal Register Volume 71, Number 233 (Tuesday, December 5, 2006)]
[Notices]
[Pages 70517-70518]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20539]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-07-0670]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
Evaluation of Efficacy of Household Water Filtration/Treatment
Devices in Households with Private Wells--Revision (OMB No. 0920-
0670)--National Center for Environmental Health (NCEH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Approximately 42.4 million people in the United States are served
by private wells. Unlike community water systems, private wells are not
regulated by the U.S. Environmental Protection Agency's (EPA) Safe
Drinking Water Act (SDWA). Under the SDWA, EPA sets maximum contaminant
levels (MCLs) for contaminants in drinking water. A 1997 U.S. General
Accounting Office (GAO) report on drinking water concluded that users
of private wells may face higher exposure levels to groundwater
contaminants than users of community water systems. Increasingly, the
public is concerned about drinking water quality, and the public's use
of water treatment devices rose from 27% in 1995 to 41% in 2001 (Water
Quality Association, 2001 National Consumer Water Quality Survey).
Studies evaluating the efficacy of water treatment devices on removal
of pathogens and other contaminants have assessed the efficacy of
different treatment technologies.
The purpose of the proposed study is to evaluate how water
treatment device efficacy is affected by user behaviors such as
maintenance and selection of appropriate technologies. Working with
public health authorities in Colorado, Maine, Missouri, Nebraska, North
Carolina, and Wisconsin, NCEH will recruit 600 households to
participate in a study to determine whether people using water
treatment devices are protected from exposure to contaminants found in
their well water. We plan to recruit households on private well water
that use water filtration/treatment devices to treat tap water for
drinking and cooking. Study participants will be selected from
geographical areas of each state where groundwater is known or
suspected to contain contaminants of public health concern. We will
administer a questionnaire at each household to obtain information on
selection of water treatment type, adherence to suggested maintenance,
and reasons for use of treatment device. We will also obtain samples of
treated water and untreated well water at each household to analyze for
contaminants of public health concern. There is no cost to respondents
[[Page 70518]]
other than their time. The total estimated annual burden hours are 300.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Respondents respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Participant Solicitation Telephone Screening Questionnaire...... 1200 1 5/60
Household Survey Questionnaire.................................. 600 1 20/60
----------------------------------------------------------------------------------------------------------------
Dated: November 28, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-20539 Filed 12-4-06; 8:45 am]
BILLING CODE 4163-18-P
